Swiss National Bank Biotechnology

Swiss National Bank

$150 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
IMNM Immunome Inc.	$133M	$1.12 Million 0.0% of portfolio	76,400	Q2 2024 Added 7.0%
ARCT Arcturus Therapeutics Holdings Inc.	$411M	$1.11 Million 0.0% of portfolio	47,700	Q2 2024 Added 1.06%
ABUS Arbutus Biopharma Corp	$481M	$1.06 Million 0.0% of portfolio	276,300	Q3 2024 New
PLRX Pliant Therapeutics, Inc.	$643M	$1.06 Million 0.0% of portfolio	94,200	Q3 2024 Added 6.56%
ETNB 89bio, Inc.	$369M	$1.04 Million 0.0% of portfolio	140,500	Q2 2024 Reduced 4.55%
IBRX Immunity Bio, Inc.	$1.05B	$1 Million 0.0% of portfolio	270,000	Q3 2024 Added 2.62%
SANA Sana Biotechnology, Inc.	$314M	$989,000 0.0% of portfolio	237,900	Q3 2024 Reduced 8.57%
ERAS Erasca, Inc.	$310M	$900,000 0.0% of portfolio	329,700	Q3 2024 New
LQDA Liquidia Corp	$714M	$895,000 0.0% of portfolio	89,500	Q3 2024 Reduced 7.92%
HUMA Humacyte, Inc.	$478M	$885,000 0.0% of portfolio	162,700	Q3 2024 New
ALT Altimmune, Inc.	$404M	$856,000 0.0% of portfolio	139,500	Q2 2024 Added 31.6%
RGNX Regenxbio Inc.	$329M	$854,000 0.0% of portfolio	81,500	Q1 2024 Added 4.49%
SVRA Savara Inc	$368M	$808,000 0.0% of portfolio	190,800	Q3 2024 Added 29.8%
YMAB Y M Abs Therapeutics, Inc.	$362M	$791,000 0.0% of portfolio	60,300	Q2 2024 New
OLMA Olema Pharmaceuticals, Inc.	$247M	$788,000 0.0% of portfolio	66,000	Q2 2024 Reduced 6.12%
EYPT Eye Point Pharmaceuticals, Inc.	$242M	$771,000 0.0% of portfolio	96,600	Q3 2024 Added 3.76%
ALLO Allogene Therapeutics, Inc.	$269M	$741,000 0.0% of portfolio	264,900	Q3 2024 Reduced 7.7%
REPL Replimune Group, Inc.	$616M	$722,000 0.0% of portfolio	65,900	Q3 2024 Reduced 22.01%
URGN Uro Gen Pharma Ltd.	$242M	$718,000 0.0% of portfolio	56,600	Q3 2024 New
STOK Stoke Therapeutics, Inc.	$460M	$687,000 0.0% of portfolio	55,900	Q3 2024 Reduced 15.81%
SRRK Scholar Rock Holding Corp	$2.31B	$674,000 0.0% of portfolio	84,200	Q2 2024 Added 7.54%
NUVB Nuvation Bio Inc.	$582M	$667,000 0.0% of portfolio	290,100	Q3 2024 Added 9.14%
ATXS Astria Therapeutics, Inc.	$145M	$648,000 0.0% of portfolio	58,900	Q3 2024 New
TNGX Tango Therapeutics, Inc.	$273M	$646,000 0.0% of portfolio	83,900	Q2 2024 Added 4.61%
SAGE Sage Therapeutics, Inc.	$333M	$638,000 0.0% of portfolio	88,600	Q2 2024 Reduced 16.57%
ALEC Alector, Inc.	$154M	$615,000 0.0% of portfolio	131,900	Q1 2024 Added 6.46%
ORIC Oric Pharmaceuticals, Inc.	$325M	$606,000 0.0% of portfolio	59,200	Q3 2024 Reduced 10.71%
TYRA Tyra Biosciences, Inc.	$588M	$604,000 0.0% of portfolio	25,700	Q3 2024 New
CVAC Cure Vac N.V.	$538M	$583,000 0.0% of portfolio	198,547	Q4 2023 Reduced 10.32%
FATE Fate Therapeutics Inc	$163M	$583,000 0.0% of portfolio	166,700	Q3 2024 Reduced 6.92%
TBPH Theravance Biopharma, Inc.	$640M	$578,000 0.0% of portfolio	71,742	Q2 2024 Reduced 2.71%
VERV Verve Therapeutics, Inc.	$344M	$557,000 0.0% of portfolio	115,100	Q2 2024 Added 11.53%
FDMT 4 D Molecular Therapeutics, Inc.	$204M	$545,000 0.0% of portfolio	50,500	Q3 2024 Reduced 8.84%
EDIT Editas Medicine, Inc.	$90M	$524,000 0.0% of portfolio	153,700	Q2 2024 Added 6.15%
TRDA Entrada Therapeutics, Inc.	$552M	$524,000 0.0% of portfolio	32,800	Q2 2024 Added 42.61%
RVNC Revance Therapeutics, Inc.	$212M	$500,000 0.0% of portfolio	194,650	Q1 2024 Added 18.22%
LXRX Lexicon Pharmaceuticals, Inc.	$134M	$498,000 0.0% of portfolio	317,500	Q3 2024 New
PHVS Pharvaris N.V.	$661M	$486,000 0.0% of portfolio	26,257	Q3 2024 New
ITOS I Teos Therapeutics, Inc.	$264M	$409,000 0.0% of portfolio	40,100	Q3 2024 Reduced 12.64%
LYEL Lyell Immunopharma, Inc.	$151M	$341,000 0.0% of portfolio	247,400	Q4 2023 Reduced 8.94%
SBTX Silverback Therapeutics, Inc.	$0	$0 0.0% of portfolio	75,700	Q3 2024 Added 14.7%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.